Genomtec S.A. (GMT) — Financial Flexibility Index
Genomtec S.A. (GMT) has a Financial Flexibility Index of -0.37x as of September 2025. Free cash flow of zł-2.17 Million (operating CF zł-2.20 Million minus capex zł21.00K) represents 0% of total liabilities (zł5.84 Million). Also explore Genomtec S.A. (GMT) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Genomtec S.A. Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Genomtec S.A. across 6 annual periods. Check Genomtec S.A. strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Genomtec S.A. (2019–2024)
Year-by-year free cash flow to debt coverage for Genomtec S.A.. For the full company profile including market capitalisation, see Genomtec S.A. stock valuation.
| Year | Flexibility Index | Free Cash Flow (PLN) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.71x | zł-6.66 Million | zł-6.72 Million | zł9.44 Million | ▼ -22.2% |
| 2023 | -0.58x | zł-4.42 Million | zł-7.95 Million | zł7.67 Million | ▼ -825.7% |
| 2022 | 0.08x | zł546.00K | zł-3.79 Million | zł6.87 Million | ▲ +105.2% |
| 2021 | -1.53x | zł-5.32 Million | zł-5.53 Million | zł3.48 Million | ▼ -15.1% |
| 2020 | -1.33x | zł-2.39 Million | zł-2.52 Million | zł1.80 Million | ▼ -98.7% |
| 2019 | -0.67x | zł-1.20 Million | zł-1.69 Million | zł1.80 Million | — |